Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease
- PMID: 21183586
- PMCID: PMC3052214
- DOI: 10.2215/CJN.05040610
Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease
Abstract
Background and objectives: Patients with advanced chronic kidney disease (CKD) are in positive phosphorus balance, but phosphorus levels are maintained in the normal range through phosphaturia induced by increases in fibroblast growth factor-23 (FGF23) and parathyroid hormone (PTH). This provides the rationale for recommendations to restrict dietary phosphate intake to 800 mg/d. However, the protein source of the phosphate may also be important.
Design, setting, participants, & measurements: We conducted a crossover trial in nine patients with a mean estimated GFR of 32 ml/min to directly compare vegetarian and meat diets with equivalent nutrients prepared by clinical research staff. During the last 24 hours of each 7-day diet period, subjects were hospitalized in a research center and urine and blood were frequently monitored.
Results: The results indicated that 1 week of a vegetarian diet led to lower serum phosphorus levels and decreased FGF23 levels. The inpatient stay demonstrated similar diurnal variation for blood phosphorus, calcium, PTH, and urine fractional excretion of phosphorus but significant differences between the vegetarian and meat diets. Finally, the 24-hour fractional excretion of phosphorus was highly correlated to a 2-hour fasting urine collection for the vegetarian diet but not the meat diet.
Conclusions: In summary, this study demonstrates that the source of protein has a significant effect on phosphorus homeostasis in patients with CKD. Therefore, dietary counseling of patients with CKD must include information on not only the amount of phosphate but also the source of protein from which the phosphate derives.
Trial registration: ClinicalTrials.gov NCT00764816.
Figures



Comment in
-
Source matters: from phosphorus load to bioavailability.Clin J Am Soc Nephrol. 2011 Feb;6(2):239-40. doi: 10.2215/CJN.11051210. Epub 2011 Feb 3. Clin J Am Soc Nephrol. 2011. PMID: 21292849 No abstract available.
References
-
- Bricker NS: On the pathogenesis of the uremic state. An exposition of the “trade-off hypothesis”. N Engl J Med 286: 1093–1099, 1972 - PubMed
-
- Nagano N, Miyata S, Abe M, Kobayashi N, Wakita S, Yamashita T, Wada M: Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats. Kidney Int 69: 531–537, 2006 - PubMed
-
- Moe SM: Current issues in the management of secondary hyperparathyroidism and bone disease. Perit Dial Int 21[Suppl 3]: S241–S246, 2001 - PubMed
-
- Kidney Disease Outcomes Quality Initiative, National Kidney Foundation: Clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kid Dis 42: S1–S201, 2003 - PubMed
-
- Kyriazis J, Stamatiadis D, Mamouna A: Intradialytic and interdialytic effects of treatment with 1.25 and 1. 75 Mmol/L of calcium dialysate on arterial compliance in patients on hemodialysis. Am J Kidney Dis 35: 1096–1103, 2000 - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical